25 results
8-K
EX-10.1
PCSA
Processa Pharmaceuticals Inc
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure
8-K
EX-10.1
kjc6renu9ch6rw9ydi
24 Mar 22
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-1.1
eqbkzqqrton8hu
20 Aug 21
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-10.1
rb73ajbn8cjial
18 Feb 21
Processa Pharmaceuticals Announces $10.2 Million Strategic Financing
10:08am
424B4
kc9o 4l7b38bf1lr60d
5 Oct 20
Prospectus supplement with pricing info
4:16pm
8-K
EX-10.1
2lb56si1f dar3kdtjnk
20 Aug 20
Entry into a Material Definitive Agreement
9:30am
424B3
f00pjs 5jwbc1m5e29
9 Nov 18
Prospectus supplement
5:04pm